Healthcare professionals' knowledge, confidence and perceptions of pharmacogenomics in primary care and pain management

被引：5
作者：
Behr, Matthew P. [1 ]
Gammal, Roseann S. [1 ]
Matthews, Michele L. [1 ,2 ]
Wang, Victor C. [3 ]
机构：
[1] Massachusetts Coll Pharm & Hlth Sci, Dept Pharm Practice, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Pain Management Ctr, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Neurol, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA
来源：
PHARMACOGENOMICS | 2023年
关键词：
pain management; personalized patient care plan; pharmacogenomics; primary care; survey; PHYSICIANS; SUPPORT;
D O I：
10.2217/pgs-2023-0028
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Aim: To assess knowledge, confidence and perceptions of healthcare professionals specializing in primary care and pain management at Brigham and Women's Hospital, related to clinical pharmacogenomics (PGx). Methods: A 25-question online survey was distributed to 328 Brigham and Women's Hospital clinicians for analysis. Results: Thirty-four clinicians completed the survey. Respondents had minimal experience with PGx and limited awareness of PGx resources. Although respondents expressed belief that PGx has utility to improve medication-related patient outcomes, many lack confidence to apply PGx results to their practice. For clinical drug-gene questions relevant to primary care and/or pain management, respondents scored poorly. Conclusion: More clinician education is needed for appropriate utilization of PGx in clinical practice as it pertains to primary care and pain management.
引用
收藏
页码：371 / 379
页数：9
相关论文
共 24 条
  • [1] Ethiopian health care professionals' knowledge, attitude, and interests toward pharmacogenomics
    Abdela, Ousman Abubeker
    Bhagavathula, Akshaya Srikanth
    Gebreyohannes, Eyob Alemayehu
    Tegegn, Henok Getachew
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2017, 10 : 279 - 285
  • [2] Center for Drug Evaluation and Research US FDA, 2022, TABLE PHARMACOGENOMI
  • [3] Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy
    Crews, Kristine R.
    Monte, Andrew A.
    Huddart, Rachel
    Caudle, Kelly E.
    Kharasch, Evan D.
    Gaedigk, Andrea
    Dunnenberger, Henry M.
    Leeder, J. Steven
    Callaghan, John T.
    Samer, Caroline Flora
    Klein, Teri E.
    Haidar, Cyrine E.
    Van Driest, Sara L.
    Ruano, Gualberto
    Sangkuhl, Katrin
    Cavallari, Larisa H.
    Muller, Daniel J.
    Prows, Cynthia A.
    Nagy, Mohamed
    Somogyi, Andrew A.
    Skaar, Todd C.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (04) : 888 - 896
  • [4] Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
    Dunnenberger, Henry M.
    Crews, Kristine R.
    Hoffman, James M.
    Caudle, Kelly E.
    Broeckel, Ulrich
    Howard, Scott C.
    Hunkler, Robert J.
    Klein, Teri E.
    Evans, William E.
    Relling, Mary V.
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55, 2015, 55 : 89 - +
  • [5] Expanding evidence leads to new pharmacogenomics payer coverage
    Empey, Philip E.
    Pratt, Victoria M.
    Hoffman, James M.
    Caudle, Kelly E.
    Klein, Teri E.
    [J]. GENETICS IN MEDICINE, 2021, 23 (05) : 830 - 832
  • [6] Documenting Pharmacogenomic Test Results in Electronic Health Records: Practical Considerations for Primary Care Teams
    Gammal, Roseann S.
    Berenbrok, Lucas A.
    Empey, Philip E.
    Massart, Mylynda B.
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [7] Ready or not, here it comes: Direct-to-consumer pharmacogenomic testing and its implications for community pharmacists
    Gammal, Roseann S.
    Mayes, Jason
    Caudle, Kelly E.
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2019, 59 (05) : 646 - 650
  • [8] Guidelines, 2021, GUIDELINES
  • [9] Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update
    Hicks, J. K.
    Sangkuhl, K.
    Swen, J. J.
    Ellingrod, V. L.
    Muller, D. J.
    Shimoda, K.
    Bishop, J. R.
    Kharasch, E. D.
    Skaar, T. C.
    Gaedigk, A.
    Dunnenberger, H. M.
    Klein, T. E.
    Caudle, K. E.
    Stingl, J. C.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (01) : 37 - 44
  • [10] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
    Hicks, J. K.
    Bishop, J. R.
    Sangkuhl, K.
    Mueller, D. J.
    Ji, Y.
    Leckband, S. G.
    Leeder, J. S.
    Graham, R. L.
    Chiulli, D. L.
    LLerena, A.
    Skaar, T. C.
    Scott, S. A.
    Stingl, J. C.
    Klein, T. E.
    Caudle, K. E.
    Gaedigk, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 98 (02) : 127 - 134
123